IV infusion helps new mothers experiencing postpartum depression

MU Health Care psychiatrist works to help mothers experiencing postpartum depression through a new drug called Zulresso

July 15, 2022

Transcript

Brian Consiglio: Most new moms experience postpartum “baby blues” after childbirth, which may include mood swings, anxiety and difficulty sleeping. In fact, MU Health Care psychiatrist Kimberly Brandt explained that about 1 in 8 women experience postpartum depression.

Brandt: The theory is really that the major hormone shift that happens right after delivery can sometimes cause an imbalance of hormones that can affect mood and anxiety in the brain.

Consiglio: Brandt specializes in taking care of mothers both before and after birth. She has helped some of her patients with a new treatment option called Zulresso, a FDA-approved drug given through an IV infusion during the course of 60 hours that is specifically designed to reduce postpartum depression.

Brandt: While other medications like antidepressants can be helpful, the real benefit is how quickly the symptoms can be reduced.

Consiglio: Brandt’s message to new mothers is that investing in yourself is worth it, and that reaching out to ask for help is not a sign a weakness, it is a sign of strength.

For more on this treatment option, visit muhealth.org.

I’m Brian Consiglio, with a Spotlight on Mizzou.

Learn more about the research here

Subscribe to

Show Me Mizzou

Stay up-to-date with the latest news by subscribing to the Show Me Mizzou newsletter.

Subscribe